EUVIMEDEUVIMED entdecken
Crossref

Tolypocladium sinense Mycelium Polysaccharide Alleviates Obesity, Lipid Metabolism Disorder, and Inflammation Caused by High Fat Diet via Improving Intestinal Barrier and Modulating Gut Microbiota

Mingjian Bai iD, Xiaolong Wang, Dongyang Liu, Aofeng Xu, Hao Cheng, Lin Li, Chunjing Zhang

Molecular Nutrition & Food Research · 2024

DOI: 10.1002/mnfr.202300759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Mingjian Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology, Qiqihar Medical University, Qiqihar, Heilongjiang, 161006, China. Hauptthemen laut MEDLINE: Diet, High-Fat, Gastrointestinal Microbiome, Obesity, Mice, Inbred C57BL. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Projects of Basic Scientific Research of Heilongjiang Education Department, Natural Science Foundation of Heilongjiang Province, graduate student innovation fund program of Qiqihar Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scope Tolypocladium sinense is a fungus isolated from Cordyceps. Cordyceps has some medicinal value and is also a daily health care product. This study explores the preventive effects of T. sinense mycelium polysaccharide (TSMP) on high‐fat diet‐induced obesity and chronic inflammation in mice. Methods and results Here, the study establishes an obese mouse model induced by high‐fat diet. In this study, the mice are administered TSMP daily basis to evaluate its effect on alleviating obesity. The results show that TSMP can significantly inhibit obesity and alleviate dyslipidemia by regulating the expression of lipid metabolism‐related genes such as liver kinase B1 (LKB1), phosphorylated AMP‐activated protein kinase (pAMPK), peroxisome proliferator activated receptor α (PPARα), fatty acid synthase (FAS), and hydroxymethylglutaryl‐CoA reductase (HMGCR) in the liver. TSMP can increase the protein expression of zona occludens‐1 (ZO‐1), Occludin, and Claudin‐1 in the colon, improve the intestinal barrier dysfunction, and reduce the level of serum LPS, thereby reducing the inflammatory response. 16S rDNA sequencing shows that TSMP alters the intestinal microbiota by increasing the relative abundance of Akkermansia , Lactobacillus , and Prevotellaceae_NK3B31_group , while decreasing the relative abundance of Faecalibaculum . Conclusion The findings show that TSMP can inhibit obesity and alleviates obesity‐related lipid metabolism disorders, inflammatory responses, and oxidative stress by modulating the gut microbiota and improving intestinal barrier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, High-FatGastrointestinal MicrobiomeObesityMice, Inbred C57BLMyceliumInflammationAnimalsMaleLipid Metabolism DisordersMiceLipid MetabolismPolysaccharidesHypocrealesIntestinal MucosaFungal PolysaccharidesLiver

Stichwörter der Autor:innen

Gut microbiotaIntestinal barrierObesityPolysaccharidesTolypocladium sinense

Substanzen

PolysaccharidesFungal Polysaccharides

Autor:innen und Institutionen

  • Department of Medical Technology, Qiqihar Medical University, Qiqihar, Heilongjiang, 161006, China.
  • School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China.
  • First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, China.
  • Special Medical Service Department Section Four, People's Liberation Army Strategic Support Force, Characteristics Medical Center, Beijing, 100000, China.
  • Qiqihar Medical University Clinical Department, Qiqihar Medical University, Qiqihar, Heilongjiang, 161006, China.

ORCID-Profile: Mingjian Bai

Förderung

  • Projects of Basic Scientific Research of Heilongjiang Education Department
  • Natural Science Foundation of Heilongjiang Province
  • graduate student innovation fund program of Qiqihar Medical University
  • Qiqihar Science and Technology Plan Joint Guidance Project

Zitieren

APA

Bai, M., Wang, X., Liu, D., Xu, A., Cheng, H., Li, L., & Zhang, C. (2024). Tolypocladium sinense Mycelium Polysaccharide Alleviates Obesity, Lipid Metabolism Disorder, and Inflammation Caused by High Fat Diet via Improving Intestinal Barrier and Modulating Gut Microbiota. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300759

Vancouver

Bai M, Wang X, Liu D, Xu A, Cheng H, Li L, et al. Tolypocladium sinense Mycelium Polysaccharide Alleviates Obesity, Lipid Metabolism Disorder, and Inflammation Caused by High Fat Diet via Improving Intestinal Barrier and Modulating Gut Microbiota. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300759

BibTeX
@article{Bai2024,
  author = {Bai, Mingjian and Wang, Xiaolong and Liu, Dongyang and Xu, Aofeng and Cheng, Hao and Li, Lin and Zhang, Chunjing},
  title = {Tolypocladium sinense Mycelium Polysaccharide Alleviates Obesity, Lipid Metabolism Disorder, and Inflammation Caused by High Fat Diet via Improving Intestinal Barrier and Modulating Gut Microbiota},
  journal = {Molecular Nutrition & Food Research},
  year = {2024},
  doi = {10.1002/mnfr.202300759}
}
Kostenlos starten →